At a glance
- Originator Fujimoto Pharmaceutical
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetes mellitus; Hyperlipidaemia
Most Recent Events
- 28 Mar 2001 Preclinical development for Diabetes mellitus in Japan (Unknown route)
- 28 Mar 2001 Preclinical development for Hyperlipidaemia in Japan (Unknown route)